AzTrials
AzTrials

Incisional HerniaNCT01507870

Randomized Controlled Prospective Multicenter Study Primary Onlay- Mesh After Elective Median Laparotomy in Patients With BMI ≥ 27

A study testing onlay mesh placement in people with Incisional Hernia and Obesity, run by Austrian Hernia Study Group at 1 site in Austria.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Incisional hernia is one ot the most frequently seen long term complications in abdominal surgery. Despite studies on the optimal suturing technique for laparotomies, the risk for incisional hernia after midline incision remains about 5-20 %. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Incisional Hernia, Obesity
What is being tested?
onlay mesh placement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteAustria
Study dates
Jan 2010to Jan 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Every elective midline laparotomy for patients with a BMI of more than 27. Signed informed consent
  • Previous midline incision
  • Life expectancy less than 24 months
  • Pregnant women
  • Immune suppression therapy within 2 weeks before surgery

Who cannot join

  • Age < 18 years
  • Emergency procedure

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Study site

    Wiener Neustadt, Lower Austria, 2700

Other trials in Austria

About this study

Incisional hernia is one ot the most frequently seen long term complications in abdominal surgery. Despite studies on the optimal suturing technique for laparotomies, the risk for incisional hernia after midline incision remains about 5-20 %. One major risk factor for incisional hernia after a median laparotomy is obesity.

The closure technique of midline incisions has remained unchanged since many decades and primarily consists of suturing the linea alba. Interest in prevention of incisional hernias with the aid of synthetic mesh is growing and only one large randomized trial is active recruiting patients in Germany, Netherlands and Belgium (Prima Trial).

Read more

Patients with a BMI of more than 27 have a high risk of developing an incisional hernia after midline incision with an incidence of 22% after 12 months. This high risk group of patients may benefit from prevention.

Some small studies have been performed to evaluate the usefulness and safety of primary laparotomy wound closure with the aid of prosthetic mesh. These studies show a very low risk for incisional hernias and a low infection rate, even when used in contaminated wounds such as colostomy surgery.

The goal of this study is to evaluate the effectiveness of incisional hernia prevention after elective median laparotomy in patients with a BMI of more than 27. A randomized controlled trial will be performed comparing the commonly used technique of running suture to close with the aid of a prosthetic onlay mesh. The primary outcome measure will be incisional hernia occurrence. Secondary outcome measures will be complications, surgical site infections, post-operative pain and quality of life.

Being tested
onlay mesh placement
Keywords
body mass index
Medical subject headings
Incisional Hernia, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • onlay mesh placementProcedure or surgery

    prophylactic onlay mesh in patients with median laparotomy

Study groups in NCT01507870
Study groupRoleWhat they receive
prophylactic onlay meshActive comparatorNot described
Receives: Procedure: onlay mesh placement
continuous running sutureNo interventioncontinuous running suture of the linea alba

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incisional hernia occurrence

    Measured: 3 years

Secondary outcomes (3)
  1. complications

    haematoma formation, seroma formation, surgical site infection (SSI - classification)

    Measured: 3 years

  2. postoperative pain

    VAS

    Measured: 14 days postoperative

  3. life quality

    MOS SF-36

    Measured: 14 days postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2012 (estimated)
  2. Study startJan 2010
  3. Primary completionJan 2013
  4. Study completionJan 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01507870
Sponsor's protocol ID
Primary Onlay
Status last verified
Jul 2015
First submitted
5 Jan 2012
Last updated
2 Jul 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing onlay mesh placement in people with Incisional Hernia and Obesity, run by Austrian Hernia Study Group at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 2 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early. Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incisional hernia occurrence (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in